Beyond Air, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Beyond Air, Inc. (XAIR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.81 million shares for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-22.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2023-06-22
- Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-03-31 was 1.01M shares, a 28.73% increase year-over-year.
- Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-12-31 was -20.00K shares.
- Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-09-30 was 20.00K shares, a 0.00% change year-over-year.
- Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-06-30 was 122.00K shares, a 1120.00% increase year-over-year.
- Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.81M shares, a 67.64% increase from fiscal 2022.
- Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.67M shares, a 47.77% increase from fiscal 2021.
- Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 1.13M shares, a 38.96% increase from fiscal 2020.
- Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 815.00K shares, a 57.53% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2023-03-31 | 2.81M shares 10-K · filed 2023-06-22 | ||||
| 2022-03-31 | 1.67M shares 10-K · filed 2023-06-22 | 1.76M shares 10-K · filed 2022-06-29 | |||
| 2021-03-31 | 1.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10 | 990.50K shares derived: sum of 2 quarters · filed 2021-06-10 | 1.01M shares derived: sum of 3 quarters · filed 2021-06-10 | 1.13M shares 10-K · filed 2021-06-10 | |
| 2020-12-31 | -20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | 0.00 shares derived: sum of 2 quarters · filed 2021-02-09 | 122.00K shares 10-Q · filed 2021-02-09 | 907.00K shares derived: sum of 4 quarters · filed 2021-06-10 | |
| 2020-09-30 | 20.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | 142.00K shares 10-Q · filed 2020-11-12 | 927.00K shares derived: sum of 3 quarters · filed 2021-06-10 | 927.00K shares derived: sum of 4 quarters · filed 2021-06-10 | |
| 2020-06-30 | 122.00K shares 10-Q · filed 2020-08-06 | 907.00K shares derived: sum of 2 quarters · filed 2021-06-10 | 907.00K shares derived: sum of 3 quarters · filed 2021-06-10 | 927.00K shares derived: sum of 4 quarters · filed 2021-06-10 | |
| 2020-03-31 | 785.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10 | 785.00K shares derived: sum of 2 quarters · filed 2021-06-10 | 805.00K shares derived: sum of 3 quarters · filed 2021-06-10 | 815.00K shares 10-K · filed 2021-06-10 | |
| 2019-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-07 | 20.00K shares derived: sum of 2 quarters · filed 2020-02-07 | 30.00K shares 10-Q · filed 2020-02-07 | ||
| 2019-09-30 | 20.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06 | 30.00K shares 10-Q · filed 2019-11-06 | |||
| 2019-06-30 | 10.00K shares 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | 1.92M shares 10-K · filed 2020-06-23 | ||||
| 2018-06-30 | 245.78K shares 10-Q · filed 2018-08-14 | 501.16K shares derived: sum of 2 quarters · filed 2018-08-14 | |||
| 2018-03-31 | 255.38K shares 10-KT · filed 2018-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |